Dees, Sundee <br/><br/>
Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer.  [electronic resource] 

 -  Cancer biology & therapy  06 2020 
 - 506-521 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1555-8576 
<br/><br/><label>Standard No.: </label>10.1080/15384047.2020.1726718  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis<br/>Biomarkers, Tumor--metabolism<br/>Cell Movement<br/>Cell Proliferation<br/>Dopamine Antagonists--pharmacology<br/>Female<br/>Humans<br/>Phosphorylation<br/>Pimozide--pharmacology<br/>STAT3 Transcription Factor--genetics<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Tumor Cells, Cultured